Streetbeat News

Products Services

TRUG

TruGolf Holdings Inc (NASDAQ:TRUG) stock surged 52% to $1.75 after announcing a partnership with AI firm mlSpatial to enhance its APOGEE launch monitor. The collaboration involves integrating an advanced AI engine and gives TruGolf an option to acquire mlSpatial's assets in the future.

Portfolio Pulse from Henry Khederian

March 20, 2024 | 2:11 pm

SOPH

SOPHiA GENETICS announced its first customer in Canada for Homologous Recombination Deficiency (HRD) testing, marking a significant milestone in its expansion and adoption of its genetic testing services in the country.

Portfolio Pulse from Benzinga Newsdesk

March 20, 2024 | 2:02 pm

ALKT

Alkami has developed a Digital Sales & Service Maturity Model Assessment aimed at measuring digital maturity in financial institutions. This tool follows the company's recent research initiative focused on the same area.

Portfolio Pulse from Benzinga Newsdesk

March 20, 2024 | 2:01 pm

TRUG

TruGolf's stock price increased following the announcement of an expanded AI technology licensing agreement with mlSpatial. This partnership is expected to enhance TruGolf's offerings by incorporating advanced AI capabilities.

Portfolio Pulse from Benzinga Newsdesk

March 20, 2024 | 2:01 pm

NRIX

Nurix Therapeutics presented the discovery and chemical structure of its CBL-B inhibitor, NX-1607, at the American Chemical Society meeting. The presentation emphasized Nurix's role in targeted protein modulation and the unique mechanism of action of NX-1607, which acts as an intramolecular glue to lock the E3 ligase CBL-B in an inactive state. A Phase 1 trial is currently underway for NX-1607 as a monotherapy and in combination with paclitaxel for various oncology indications.

Portfolio Pulse from Benzinga Newsdesk

March 20, 2024 | 1:45 pm

DIS

GOOG

TTD

Disney has announced a strategic shift in its approach to selling CTV (Connected TV) ads by partnering with Google and The Trade Desk. This move aims to expand Disney's advertising reach and capabilities in the digital and CTV advertising markets.

Portfolio Pulse from Benzinga Newsdesk

March 20, 2024 | 1:41 pm

LIVN

LivaNova's shares surged following the announcement of a positive predictive outcome in its OSPREY clinical study for treating obstructive sleep apnea, leading to an early conclusion of enrollment.

Portfolio Pulse from Benzinga Newsdesk

March 20, 2024 | 1:38 pm

UAVS

AgEagle Aerial Systems Inc. has announced the sale of 50 RedEdge-P Multispectral Sensors to the Greek Ministry of Agriculture. This sale is part of a tender award to a consortium that includes ALVO. The sensors are expected to enhance agricultural productivity and sustainability in Greece.

Portfolio Pulse from Benzinga Newsdesk

March 20, 2024 | 1:37 pm

NVDA

QQQ

SPY

TSLA

Despite fading hopes for a March rate cut by the Federal Reserve, the S&P 500 index remains near record levels, driven by the historic hype around AI. The SPDR S&P 500 ETF (SPY) closely tracks this performance. Adam Kobeissi attributes market resilience to AI's strength, despite the Fed's cautious stance on inflation and rate cuts. Earnings season showed positive results, with significant contributions from tech and AI companies like Nvidia, which added $1 trillion to its market cap. However, Tesla reported slowing demand. The Invesco QQQ Trust (QQQ) also saw a notable gain, outperforming SPY.

Portfolio Pulse from Neil Dennis

March 20, 2024 | 1:22 pm

CELU

Celularity has submitted a request to the US FDA for Orphan Drug Designation for its asset PDA-002, aimed at treating Facioscapulohumeral Muscular Dystrophy. This step is crucial for the development and potential market exclusivity of PDA-002 in treating this rare muscular dystrophy.

Portfolio Pulse from Benzinga Newsdesk

March 20, 2024 | 1:16 pm